Keyphrases
Improved Survival
100%
Brachytherapy
100%
Endometrial Adenocarcinoma
100%
Population Analysis
100%
Overall Survival
72%
Cause-specific Survival
72%
Confidence Interval
54%
Hazard Ratio
54%
External Beam Radiation
27%
Multivariate Analysis
18%
United States
9%
Young Patients
9%
Radiation Therapy
9%
Cancer Patients
9%
Kaplan-Meier
9%
Surveillance Epidemiology
9%
Treatment Regimen
9%
National Cancer Institute
9%
Prognostic Factors
9%
Cox Proportional Hazards Regression Model
9%
Recurrent Endometrial Cancer
9%
Material Data
9%
End Results Database
9%
Limit Method
9%
Product-limit
9%
Coarsened Exact Matching
9%
Nursing and Health Professions
Brachytherapy
100%
Endometrium Carcinoma
100%
Overall Survival
72%
Cause Specific Survival
72%
Confidence Interval
54%
Hazard Ratio
54%
External Beam Radiotherapy
27%
Multivariate Analysis
18%
Proportional Hazards Model
9%
National Health Organization
9%
Vascular Guide Wire
9%
Endometrium Cancer
9%
Radiotherapy
9%
Medicine and Dentistry
Endometrium Carcinoma
100%
Brachytherapy
100%
Overall Survival
72%
Cause Specific Survival
72%
Hazard Ratio
54%
External Beam Radiotherapy
27%
Multivariate Analysis
18%
Malignant Neoplasm
9%
Proportional Hazards Model
9%
Surveillance, Epidemiology, and End Results
9%
Prognostic Factor
9%
Uterine Cancer
9%
Radiation Therapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Endometrium Carcinoma
100%
Cause Specific Survival
100%
Malignant Neoplasm
12%
Endometrium Cancer
12%
Agricultural and Biological Sciences
Confidence Interval
100%
Multivariate Analysis
33%
Malignant Neoplasm
33%